万孚生物获全自动核酸提纯及实时荧光PCR分析系统等产品注册证

Core Viewpoint - Guangzhou Wanfu Biological Technology Co., Ltd. has received a medical device registration certificate from the National Medical Products Administration for its fully automated nucleic acid purification and real-time fluorescence PCR analysis system, enhancing its product offerings in the nucleic acid testing field [1] Group 1: Product Approval and Features - The newly approved system integrates magnetic bead nucleic acid extraction and real-time fluorescence PCR detection technology, enabling fully automated operations from sample processing to result output [1] - The product addresses the clinical demand for rapid pathogen detection and human gene analysis, providing efficient and convenient testing solutions for medical institutions [1] Group 2: Product Line Expansion - The approval of the nucleic acid testing system, along with the recently certified test kits for adenovirus, mycoplasma pneumoniae, and parainfluenza virus, expands the company's product line in the nucleic acid testing sector [1] - The product suite now covers common respiratory pathogens, including influenza A and B viruses, respiratory syncytial virus, adenovirus, mycoplasma pneumoniae, and parainfluenza virus, meeting the rapid screening needs for high-incidence respiratory infectious diseases [1] Group 3: Strategic Impact - The acquisition of the medical device registration certificate enhances the company's core competitiveness and market expansion capabilities, positively impacting its development [1] - The company plans to actively promote the sales of the newly approved products [1]